Document is current
Any future updates will be listed below
-
Authors
Thomson, Hazel http://orcid.org/0000-0002-2036-5598
Oliver, Nick
Godsland, Ian F.
Darzi, Ara
Srivanichakorn, Weerachai
Majeed, Azeem
Johnston, Desmond G.
Nanditha, Arun
Snehalatha, Chamukuttan
Raghavan, Arun
Susairaj, Priscilla
Simon, Mary
Satheesh, Krishnamoorthy
Ramachandran, Ambady
Sharp, Stephen
Westgate, Kate
Brage, Søren
Wareham, Nick
-
Funding
Funding for this research was provided by:
Indian Council for Medical Research (ICMR) and the Medical Research Council (MR/J000183/1)
- License Information
-
More Information
Article History
Received: 9 August 2018
Accepted: 2 September 2018
First Online: 10 September 2018
Ethics approval and consent to participate
: Ethics approvals were received from Westminster Ethics Committee (12/LO/1322) in the UK and from the Ethics Committee of the India Diabetes Research Foundation (ECR/254/Inst/TN/2013) in India. Study protocol amendments are reviewed for approval by ethics committees when necessary. Written consent is obtained from each participant after full explanation, an information leaflet offered and time allowed for consideration. The right of the participant to refuse to participate, or continue participating, without giving reasons and without prejudicing further treatment is respected. The Chief Investigator in each country ensures that participant confidentiality is respected and local data protection requirements are met.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
